
‘Not Immediately Compliant’: What the CRS Says America’s Rescheduling Order Actually Delivers
Since President Trump issued an executive order to expedite cannabis rescheduling in December 2025, questions over the legal implications of this

Since President Trump issued an executive order to expedite cannabis rescheduling in December 2025, questions over the legal implications of this

Cannabis stocks have once again been sent flying in the wake of the latest hint of progress on cannabis rescheduling

The incoming changes to hemp classification in the US are already facing major issues, with the Government’s own Congressional Research

This week has seen another frenetic torrent of executive orders issued by the newly inaugurated President Trump, causing chaos across almost all of America’s cornerstone institutions.

The US Congressional Research Service (CRS) this week published a report on proposed amendments to the US Farm Bill, which

US congressional researchers have stated that it ‘appears likely’ the Drug Enforcement Administration (DEA) will reschedule cannabis. In a new

US cannabis stock prices have rallied once again this week following the publication of the fully unredacted 252-page cannabis rescheduling

The US Congressional Research Service (CRS) has issued a memo on issues relating to the hemp industry ahead of the